Mine Islimye Taskin

No ORCID on file · 6 papers in corpus
observational 2025
The Journal of international medical research ·doi:10.1177/03000605251386208

BackgroundThis study aimed to compare the expression patterns of hypoxia-inducible factor-1α in ovarian cyst capsules and endometrial tissue samples from patients with and without endometriosis to evaluate its potential as a biomarker of hy…

observational 2023
Medicine ·doi:10.1097/md.0000000000035539

Neutrophil gelatinase-associated lipocalin (NGAL, also known as lipocalin-2) is an acute-phase protein expressed in many tissues and plays a role in cell proliferation, regulation, and epithelial-mesenchymal transformation. Therefore, this …

other 2022
Archives of gynecology and obstetrics ·doi:10.1007/s00404-021-06393-0
lab-animal 2021
Archives of gynecology and obstetrics ·doi:10.1007/s00404-021-06104-9

PURPOSE: To investigate the histological efficacy of ranibizumab and zoledronic acid in an experimentally induced endometriosis model as compared with danazol, buserelin acetate and dienogest. METHODS: Endometrial implants were introduced …

lab-animal 2015
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115612134

OBJECTIVE: The aim of this study was to investigate the efficacy of anti-interleukin 6 (IL-6) therapy in the treatment of endometriosis in a rat model. STUDY DESIGN: After the peritoneal implantation of autologous endometrial tissue, 22 Wi…

lab-animal 2015
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.3109/09513590.2015.1077218

The aim of the study is to investigate the effects of the interleukin-6 (IL-6) blocker tocilizumab in a hyperstimulated rat model and compare it with ranibizumab, a gonadotropin-releasing hormone antagonist (GnRHA), and cabergoline. Forty-s…